Serial Number
79389998
Owner
Hanall Biopharma Co., Ltd.Attorney
John M. KimFiling Date
Dec 7, 2023
HANALL BIOPHARMA Trademark
Serial Number: 79389998 • Registration: 7617145
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
John M. Kim IPLA, LLP
4445 Eastgate Mall
Suite 200
San Diego, CA 92121
United States
Trademark Details
Filing Date
December 7, 2023
Registration Date
December 24, 2024
Published for Opposition
October 22, 2024
Goods & Services
Price comparison services; advertising services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; advertising agency services for pharmaceuticals; wholesale store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; wholesale store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations
Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research in the fields of medicine, health and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marine, aerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental monitoring services
Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonics, namely, medicines for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; parasiticides; antiemetics; bronchodilating preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; preparations of trace elements for human and animal use for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; nervines in the nature of herbal supplements; pharmaceutical preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; chemico-pharmaceutical preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; medicines for the treatment of gastrointestinal diseases; drugs for medical purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; antacids; haematogen; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; sedatives; analgesics; medical preparations for slimming purposes; dental impression material for dental and dental technical purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics; medications to treat chemical disorders